Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] SK hynix (000660 / SKHY) – Change in Chief Executive Officer (CEO) / 2024-03-27 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – Equity Futures & Options Market Measures / 2025-03-27 Disclosures
  • [Disclosure] Samsung Electro-Mechanics (009150) – Consolidated Earnings Announcement (Provisional) / 2026-04-30 Semiconductors
  • [Disclosure] Hyundai Motor (005380) – Production Halt / 2026-07-13 Automotive
  • [Research] Samsung Electro-Mechanics (009150) – SK Securities | MLCC Shortage Scenario · AI-Driven Portfolio Shift · Valuation Re-rating / 2025-11-24 RESEARCH
  • [Disclosure] Hanwha Ocean (042660) – (Correction) Execution of Sales / Supply Contract / 2026-05-28 Disclosures
  • [Disclosure] Wonik IPS (240810) – Setting of Record Date or Period for Suspension of Entry of Change in Shareholders’ Register / 2026-07-24 Disclosures
  • [Disclosure] Celltrion (068270) – Approval of Phase 3 Clinical Trial Application for CT-P13 SC (Remsima Subcutaneous) in Pediatric Ulcerative Colitis in Korea / 2025-02-24 Disclosures

[Disclosure] ALTEOGEN (196170) – Results of General Shareholders Meeting / 2025-03-31

Posted on March 31, 2025August 5, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

At Alteogen’s 17th Annual General Meeting of Shareholders, all six proposed agenda items were approved as originally submitted, including the approval of financial statements, the re-election of CEO Soon Jae Park, the new appointment of Vice President Sang Lak Choi as Inside Director, and the approval of stock option grants.

📊 [Key Disclosure Details & Financial Highlights]

  • Date of Shareholders Meeting: 2025-03-31
  • Approval of 17th Financial Statements (Auditor’s Opinion: Unqualified for both Separate and Consolidated)
    • Consolidated Financial Statements (Unit: KRW Millions)
      • Total Assets: 409,012
      • Total Liabilities: 134,921
      • Total Equity: 274,091 (Capital Stock: 26,659)
      • Revenue: 102,855
      • Operating Profit: 25,404
      • Net Income: 60,690
      • Earnings Per Share: KRW 1,172
    • Separate Financial Statements (Unit: KRW Millions)
      • Total Assets: 331,648
      • Total Liabilities: 30,521
      • Total Equity: 301,127 (Capital Stock: 26,659)
      • Revenue: 92,969
      • Operating Profit: 30,630
      • Net Income: 71,233
      • Earnings Per Share: KRW 1,341
  • Dividend Details: N/A (No cash or stock dividend)
  • Voting Results by Agenda Item:
    • Agenda 1: Approval of 17th Consolidated Financial Statements and Financial Statements ☞ Approved as original
    • Agenda 2: Appointment of Directors
      • Agenda 2-1: Re-appointment of Inside Director Soon Jae Park (3-year term, Current CEO) ☞ Approved as original
      • Agenda 2-2: New appointment of Inside Director Sang Lak Choi (3-year term, Current Vice President) ☞ Approved as original
    • Agenda 3: New appointment of Standing Auditor Jung Min Lee (3-year term) ☞ Approved as original
    • Agenda 4: Approval of Director Remuneration Limit ☞ Approved as original
    • Agenda 5: Approval of Auditor Remuneration Limit ☞ Approved as original
    • Agenda 6: Approval of Stock Option Grant ☞ Approved as original
  • Executive Status Post-Meeting: Total 6 Directors (2 Outside Directors, 33.3% ratio), 1 Standing Auditor

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Reflection of Approved Financial Statements and Board Composition in Official Reports

Through this General Shareholders Meeting, the 17th financial statements were officially approved and the appointments of key management members, including CEO Soon Jae Park, were passed. Verifying that the final audited financial figures and updated executive board information match the official corporate filings is important to confirm the consistency of finalized earnings and governance structure. Details can be verified in the ‘Annual Report’ submitted in March 2025 and the ‘Financial Statements’ and ‘Executive and Employee Matters’ sections of subsequent periodic reports.

📢 Disclaimer & Source Information

Source: This content was structured and generated based on official submission data from the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).

Investment Risk Warning: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: For inquiries regarding regulatory compliance or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] Hanwha Systems (272210) – Sales / Supply Contract / 2025-03-31
Next Post: [Disclosure] Hanmi Semiconductor (042700) – Prospects for Operating Performance on a Consolidated Basis (Fair Disclosure) / 2025-03-31

Related Posts

  • [Disclosure] Hanwha Systems (272210) – Sales/Supply Contract / 2024-11-27 Disclosures
  • [Disclosure] SK Hynix (000660 / SKHY) – Submission of Audit Report / 2025-03-04 Semiconductors
  • [Disclosure] Hanwha Aerospace (012450) – Clarification on Rumors or Reports (Unconfirmed) / 2024-02-28 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Notice of Upcoming Earnings Release / 2024-04-18 Disclosures
  • [Disclosure] SK hynix (000660 / SKHY) – Investor Relations (IR) Presentation / 2024-01-09 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – Investor Relations (IR) Holding Announcement / 2024-04-17 Disclosures
  • [Disclosure] SK Square (402340) – Decision on Foreign Exchange Listing of Securities / 2026-06-24 Semiconductors
  • [Disclosure] SK Hynix (000660 / SKHY) – Decision on Disposal of Treasury Shares / 2026-03-30 Semiconductors
  • [Disclosure] Samsung Biologics (207940) – Sustainability Report and Related Matters (Voluntary Disclosure) / 2025-09-05 Disclosures
  • [Disclosure] Samsung Electronics (005930) – Delisting from Foreign Securities Market / 2025-02-13 Semiconductors
  • [Disclosure] Hanwha Aerospace (012450) – Execution of Single Sales or Supply Contract / 2025-12-22 Disclosures
  • [Disclosure] Hana Micron (067310) – Results of Annual General Meeting of Shareholders / 2026-03-26 Semiconductors
  • [Disclosure] Hanwha Aerospace (012450) – Major Management Matters Related to Investment Decisions / 2025-12-24 Disclosures
  • [Disclosure] SK Hynix (000660 / SKHY) – Decision on Issuance of Depositary Receipts (DR) (Correction) / 2026-07-06 Semiconductors

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme